Massachusetts S1420 regulates the administration of anti-psychotic and psychotropic substances in nursing homes.
Massachusetts S1420 amends existing law to enhance oversight of anti-psychotic and psychotropic substance administration in nursing homes. It mandates that nursing homes submit quarterly reports on such medications to the Centers for Medicare and Medicaid, which must be publicly posted on both the Department of Public Health and the nursing home's websites. Failure to submit these reports can result in monetary penalties and suspension of new admissions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.